Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,525 | 1,712 | 2,547 | 1,505 | 1,361 |
| Receivables | 4,598 | 2,990 | 5,524 | 4,587 | 5,573 |
| Inventories | 1,628 | 1,527 | 1,711 | 1,650 | 1,814 |
| TOTAL | $9,012 | $7,844 | $11,509 | $9,257 | $9,847 |
| Non-Current Assets | |||||
| PPE Net | 54 | 57 | 59 | 60 | 68 |
| Investments And Advances | 14,662 | 19,250 | 20,978 | 35,333 | 37,512 |
| Other Non-Current Assets | 2,211 | 2,392 | 2,633 | 2,803 | 2,861 |
| TOTAL | $16,927 | $21,699 | $23,670 | $38,196 | $40,441 |
| Total Assets | $25,939 | $29,543 | $35,179 | $47,453 | $50,288 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 451 | N/A | N/A |
| Accounts payable and accrued liabilities | 18,920 | 18,187 | 16,951 | 16,285 | 15,200 |
| Other current liabilities | 17,222 | 16,292 | 14,746 | 14,922 | 15,105 |
| TOTAL | $64,025 | $62,428 | $61,507 | $60,917 | $61,547 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,236 | 2,231 | N/A | 3,556 | 3,416 |
| Other Non-Current Liabilities | 16,692 | 18,528 | 21,428 | 19,310 | 20,357 |
| TOTAL | $18,928 | $20,759 | $21,428 | $22,866 | $23,773 |
| Total Liabilities | $82,953 | $83,187 | $82,935 | $83,783 | $85,320 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,866 | 63,866 | 61,846 | 53,638 | 53,638 |
| Common Shares | 64 | 62 | 62 | 54 | 54 |
| Retained earnings | -262,654 | -260,470 | -256,122 | -257,320 | -257,387 |
| Other shareholders' equity | -20,263 | -18,739 | -17,029 | -1,503 | -114 |
| TOTAL | $-57,014 | $-53,644 | $-47,756 | $-36,330 | $-35,032 |
| Total Liabilities And Equity | $25,939 | $29,543 | $35,179 | $47,453 | $50,288 |